Related Experiment Videos
vCCL2/vMIP-II, the viral master KEYmokine
Martyna Szpakowska1, Andy Chevigné2
1Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Journal of Leukocyte Biology
|December 25, 2015
Summary
Human herpesvirus-8 encodes viral CC motif chemokine 2 to disrupt host immunity and promote viral survival. This chemokine binds diverse receptors, acting as an agonist or antagonist to modulate immune cell recruitment, offering therapeutic potential.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human herpesvirus-8 (HHV-8) encodes viral CC motif chemokine 2 (vMIP-II) to manipulate host immune responses.
- vMIP-II interferes with the host chemokine receptor network, aiding viral immune evasion and survival.
Purpose of the Study:
- To review current knowledge on vMIP-II binding, signaling, and structural mimicry.
- To discuss the role and importance of vMIP-II in viral pathogenesis and therapeutic potential.
Main Methods:
- Literature review of studies on vMIP-II.
- Analysis of vMIP-II's interactions with viral and human chemokine receptors.
- Examination of vMIP-II's signaling properties (agonist/antagonist).
Main Results:
- vMIP-II binds broadly to four classes of viral and human chemokine receptors.
- It acts as both an agonist and antagonist, influencing immune cell recruitment.
- Its atypical properties make it a valuable tool for studying chemokine-receptor interactions and virus-host dynamics.
Conclusions:
- vMIP-II is a key viral factor for immune evasion and survival.
- Understanding vMIP-II's mechanisms offers potential for developing novel antiviral therapies targeting chemokine receptors.
- Further research is needed to fully elucidate vMIP-II's complex biology.